As in Q2/26, we expect a changed business mix to drive strong organic sales growth while putting som...
Despite continued external headwinds, we expect Alcadon to maintain its trend of year-on-year and qu...
Redeye comments on ExpreS2ion’s announcement that it has secured a guarantee undertaking of approxim...
* Saves SEK 25m annually from Q2'27, 6% of our '27e EBITA * .
Following Friday's guidance cut, MHP released its H1 report yesterday, confirming the picture.
Redeye keeps its Base Case and forecasts following August sales figures.
Relais announced today that Joonas Mäkipeska has been appointed as a new CFO, starting no later than...
Redeye returns with a research update after Biovica's Q1 2026/2027 report, which came in a bit below...
Late last week, it was announced that BONESUPPORT has entered into a distribution agreement with Str...
Redeye comments on Acarix's announcement of a peer-reviewed feasibility study in PLOS Digital Health...
Redeye comments on Magle's announcement that the board has resolved on the directed set-off issue to...
Redeye comments on Argo’s announcement that Disarmament Solutions Ukraine (DSUA) has been awarded a ...
Redeye comments on today's announcement that OncoZenge has filed a new medical use patent applicatio...
Redeye comments on Alzinova’s announcements of the operational start-up of the global Phase II study...
Nyligen släppte Västra Hamnen sin första analys av Precise Biometrics efter fusionen med Fingerprint...
Redeye provides an initial comment on Biovica's Q1 2026/2027 report.
* AI is increasing demand for hardware-based storage infrastructure * NetApp confirmed Dell's report...
Bittium announced today that Denmark has joined the frame agreement signed last year between Bittium...
QBIM redovisade ett förbättrat Q2 med högre intäkter, stärkt bruttomarginal och lägre kostnadsbas.
Redeye is positive about SciBase’s additional order from Castle Biosciences, worth approximately USD...